Could Gold Hit a Do...
Health Care: Drugs
Auxilium Pharmaceuticals Inc. (AUXL: NASDAQ)
$15.26 0.02 | 0.13%
05/23/13 - 04:00 PM ET
455.36K / 798.70K
Vol / Avg. Vol:15.12 / 15.24
Open / Prev. Close:14.95 - 15.43
Today's Range:13.87 - 29.37
52 Wk Range:-18.39%
Performance YTD:TheStreet Rating:
Portfolios with AUXL
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- UserGFNN Stockdiagnostics 23
- ContributorEarnings Short Squeeze Play...
- UserGFNN Stockdiagnostics 17
- ContributorStocks Rising On Unusual Vo...
- Contributor22 Biopharma Stocks With Br...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- Userinsider buying
Latest AUXL Headlines from TheStreet
- Repros CEO: My Testosterone Drug Helped Gay Cubans Have Lots of Sex 03.28.13 | 12:03 pm
- Auxilium Pharmaceuticals Inc. Stock Upgraded (AUXL) 03.22.13 | 05:03 am
- Insider Buying at Auxilium, Aveo Hints At Big Moves in 2013 12.20.12 | 07:12 am
- 4 More Stocks Jumping on Unusual Volume 12.17.12 | 03:12 pm
- Stocks Under $5: Discount Drug Name
11.29.12 | 06:11 am - Auxilium Pharmaceuticals Inc. Stock Downgraded (AUXL) 11.09.12 | 04:11 am
- Stocks Under $10: Stealth Drug Play 08.29.12 | 06:08 am
- Auxilium Pharmaceuticals Inc. Stock Upgraded (AUXL) 08.08.12 | 05:08 am
- 5 Stocks Poised to Pop on Bullish Earnings 07.30.12 | 01:07 pm
- 7 Stocks Moving Higher on Unusual Volume 06.05.12 | 07:06 am
Press Releases for AUXL
- Auxilium Pharmaceuticals, Inc. Announces Positive Top-line Data From XIAFLEX® (CCH) Frozen Shoulder Syndrome Phase IIa Study - PR Newswire 03.25.13 | 07:03 am
- Auxilium Pharmaceuticals, Inc. To Present At The Cowen And Company 33rd Annual Healthcare Conference - PR Newswire 03.04.13 | 07:03 am
- Auxilium Pharmaceuticals, Inc. To Present At The Leerink Swann Global Healthcare Conference - PR Newswire 02.12.13 | 07:02 am
- Auxilium Pharmaceuticals, Inc. Announces IMPRESS Trials Of XIALFEX® In Peyronie's Disease Were Published Online In The Journal Of Urology - PR Newswire 02.01.13 | 04:02 pm
- Auxilium Pharmaceuticals, Inc. Announces Issuance Of $350.0 Million Of 1.50% Convertible Senior Notes Due 2018 - PR Newswire 01.30.13 | 04:01 pm
- Auxilium Pharmaceuticals, Inc. And Xstelos Holdings, Inc. File Lawsuit Against Upsher-Smith Laboratories, Inc. For Infringement Of Testim® Patents - PR Newswire 01.28.13 | 05:01 pm
- Auxilium Pharmaceuticals, Inc. Announces Pricing Of $325.0 Million Of 1.50% Convertible Senior Notes Due 2018 - PR Newswire 01.25.13 | 07:01 am
- Auxilium Pharmaceuticals, Inc. Announces Offering Of Convertible Senior Notes Due 2018 - PR Newswire 01.23.13 | 04:01 pm
- Auxilium Pharmaceuticals, Inc. Announces Expansion Of Its Exclusive License For XIAFLEX® (CCH) To Include The Potential Treatment Of Cellulite As An Additional Indication - PR Newswire 01.07.13 | 07:01 am
- Auxilium Pharmaceuticals To Present At The J.P. Morgan 2013 Healthcare Conference - PR Newswire 01.03.13 | 07:01 am
Partner Headlines for AUXL
- Auxilium Pharmaceuticals Earnings: Here’s Why the Stock is Down Now - Wall St. Cheat Sheet 04.29.13 | 10:04 am
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 11.08.12 | 09:11 am
- Unusual Option Activity on Quad Witching - Benzinga 09.21.12 | 01:09 pm
- Neutral on Auxilium Pharma - Analyst Blog - NASDAQ 09.18.12 | 08:09 pm
- Update on Repros' Androxal - Analyst Blog - NASDAQ 09.14.12 | 09:09 pm
- Update on Repros' Androxal - Analyst Blog - Zacks 09.14.12 | 06:09 pm
- Auxilium Pharmaceuticals, Inc. Enters Oversold Territory - Tale of the Tape - NASDAQ 08.16.12 | 03:08 pm
- A Profitable Quarter for Auxilium - Analyst Blog - Zacks 08.02.12 | 09:08 am
- 2Q Revenues Decline at Actelion - Analyst Blog - Zacks 07.20.12 | 06:07 pm
- Canada Approves Auxilium's Xiaflex - Analyst Blog - Zacks 07.10.12 | 06:07 pm
